| MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia AR Pyzer, D Stroopinsky, H Rajabi, A Washington, A Tagde, M Coll, ... Blood, The Journal of the American Society of Hematology 129 (13), 1791-1801, 2017 | 150 | 2017 |
| Epstein− Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas E Anastasiadou, D Stroopinsky, S Alimperti, AL Jiao, AR Pyzer, ... Leukemia 33 (1), 132-147, 2019 | 144 | 2019 |
| Cabozantinib eradicates advanced murine prostate cancer by activating antitumor innate immunity A Patnaik, KD Swanson, E Csizmadia, A Solanki, N Landon-Brace, ... Cancer Discovery 7 (7), 750-765, 2017 | 128 | 2017 |
| Myeloid‐derived suppressor cells as effectors of immune suppression in cancer AR Pyzer, L Cole, J Rosenblatt, DE Avigan International journal of cancer 139 (9), 1915-1926, 2016 | 98 | 2016 |
| MUC1 Inhibition Leads to Decrease in PD-L1 Levels via Up-regulation of miRNAs AR Pyzer, D Stroopinsky, J Rosenblatt, E Anastasiadou, H Rajabi, ... Leukemia 31 (12), 2780, 2017 | 67 | 2017 |
| Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies AR Pyzer, DE Avigan, J Rosenblatt Human vaccines & immunotherapeutics 10 (11), 3125-3131, 2014 | 60 | 2014 |
| Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine MR Nahas, D Stroopinsky, J Rosenblatt, L Cole, AR Pyzer, ... British journal of haematology 185 (4), 679-690, 2019 | 57 | 2019 |
| Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma S Jain, D Stroopinsky, L Yin, J Rosenblatt, M Alam, P Bhargava, RA Clark, ... Blood, The Journal of the American Society of Hematology 126 (3), 354-362, 2015 | 47 | 2015 |
| Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease MR Nahas, RJ Soiffer, HT Kim, EP Alyea III, J Arnason, R Joyce, JH Antin, ... Blood, The Journal of the American Society of Hematology 131 (25), 2836-2845, 2018 | 38 | 2018 |
| Sensitive detection and quantification of SARS-CoV-2 in saliva MF Abasiyanik, B Flood, J Lin, S Ozcan, SJ Rouhani, A Pyzer, J Trujillo, ... Scientific reports 11 (1), 12425, 2021 | 37 | 2021 |
| Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity PS Briquez, SJ Rouhani, J Yu, AR Pyzer, J Trujillo, HL Dugan, ... Science Advances 8 (40), eabn3777, 2022 | 33 | 2022 |
| Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC 1 M Bar‐Natan, D Stroopinsky, K Luptakova, MD Coll, A Apel, H Rajabi, ... British journal of haematology 176 (6), 929-938, 2017 | 30 | 2017 |
| MUC 1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism D Stroopinsky, H Rajabi, M Nahas, J Rosenblatt, M Rahimian, A Pyzer, ... Journal of cellular and molecular medicine 22 (8), 3887-3898, 2018 | 16 | 2018 |
| Decitabine priming enhances mucin 1 inhibition mediated disruption of redox homeostasis in cutaneous T-cell lymphoma S Jain, A Washington, RK Leaf, P Bhargava, RA Clark, TS Kupper, ... Molecular cancer therapeutics 16 (10), 2304-2314, 2017 | 16 | 2017 |
| DCOne as an allogeneic cell-based vaccine for multiple myeloma RK Leaf, D Stroopinsky, AR Pyzer, AM Kruisbeek, S van Wetering, ... Journal of Immunotherapy 40 (9), 315-322, 2017 | 15 | 2017 |
| Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies SJ Rouhani, J Yu, D Olson, Y Zha, A Pezeshk, A Cabanov, AR Pyzer, ... Journal for immunotherapy of cancer 10 (6), 2022 | 13 | 2022 |
| Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction SJ Rouhani, JA Trujillo, AR Pyzer, J Yu, J Fessler, A Cabanov, EF Higgs, ... Research square, 2021 | 7 | 2021 |
| Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents ME MacDonald, RK Weathered, EC Stewart, AI Magold, A Mukherjee, ... Blood Advances 6 (24), 6249-6262, 2022 | 6 | 2022 |
| SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II PS Briquez, SJ Rouhani, J Yu, AR Pyzer, J Trujillo, HL Dugan, ... Medrxiv, 2021 | 2 | 2021 |
| Abstract S04-02: treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection A Cabanov, BA Flood, J Bloodworth, EF Higgs, J Fessler, MYK Leung, ... Clinical Cancer Research 26 (18_Supplement), S04-02-S04-02, 2020 | 2 | 2020 |
Salvia JainInstructor in Medicine, Beth Israel Deaconess Medical CenterEmail verificata su bidmc.harvard.edu
